Kyushu University Academic Staff Educational and Research Activities Database
List of Papers
Yoshikazu Yonemitsu Last modified date:2011.7.29

Professor / Faculty of Pharmaceutical Sciences

1. Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Murakami Y, Tabata T, Hasegawa M, Tobimatsu S, Sueishi K, Tatsuro Ishibashi.,PEDF gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal models.,Human Gene Therapy, 22:559-565,2010.03.
2. Suzuki H, Onimaru M, Yonemitsu Y, Maehara Y, Nakamura S, Sueishi K.,Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells.,Molecular Cancer,9:287,2010.10.
3. Kato T, Ueda Y, Kinoh H, Yoneyama Y, Matsunaga A, Komaru A, Harada Y, Suzuki H, Komiya A, Shibata S, Hasegawa M, Hayashi H, Ichikawa T, Yonemitsu Y.,RIG-I helicase-independent pathway in Sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.,Neoplasia ,12:906-914,2010.11.
4. Kondo H, Okano S, Yoshida Y, Yonemitsu Y, Tomita Y, Yoshikai Y, Wake N, Sueishi.,Semi-Allogeneic dendritic cells injected via the intratumoural injection route show efficient antitumour effects in cooperation with host-derived professional antigen-presenting cells.,The Scandinavian Journal of Immunology ,72:476-490,2010.12.
5. Onimaru M, Yonemitsu Y, Suzuki H, Fujii T, Sueishi K.,An autocrine linkage between matrix metalloproteinase-14 and Tie-2 via ectodomain shedding modulates angiopoietin-1 dependent function in endothelial cells.,Arterioscler Thromb Vasc Biol ,30:818-826,2010.01.
6. Matsunaga A, Ueda Y, Yamada S, Ishida K, Yoneyama Y, Kato T, Harada Y, Shibata S, Shimada H, Inoue M, Hasegawa M, Tsuji H, Ochiai T, Yonemitsu Y.,Carbon ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma.,Cancer, 116:3740-3748,2010.08.
7. Murakami Y, Ikeda Y, Yonemitsu Y, Miyazaki M, Inoue M, Hasegawa M, Sueishi K, Ishibashi T.,Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai virus envelope proteins.,Human Gene Therapy,21:199-209,2010.02.
8. Onimaru M, Yonemitsu Y, Fujii T, Tanii M, Nakano T, Nakagawa K, Kohno R, Hasegawa M, Nishikawa SI, Sueishi K.,VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.,Am J Physiol, Heart Circ Physiol,297:H1685-1696,2009.11.
9. Harada Y, Ueda Y, Kinoh H, Komaru A, Fuji-Ogawa T, Furuya A, Iida A, Hasegawa M, Ichikawa T, Yonemitsu Y.,Cytokine-based log-scale expansion of functional murine dendritic cells.,PLoS ONE, 4:e6674,2009.08.
10. Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Himeno K, Hisaeda H.,Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.,Vaccine ,27:6154-6159,2009.08.
11. Komaru A, Ueda Y, Furuya A, Tanaka S, Yoshida K, Kato T, Kinoh H, Harada Y, Suzuki H, Inoue M, Hasegawa M, Ichikawa T, Yonemitsu Y. ,Sustained and NK/CD4+T-cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.,The Journal of Immunology ,183:4211-4219,2009.09.
12. Matsuura M, Onimaru M, Yonemitsu Y, Nakano T, Suzuki H, Ishibashi H, Shirasuna H, Sueishi K.,Autocrine loop between VEGF-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells.,The American Journal of Pathology,175:1709-1721,2009.09.
13. Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno RI, Murakami Y, Murata T, Tabata T, Ueda Y, Ono F, Suzuki T, Ageyama N, Terao K, Hasegawa M, Sueishi K, Ishibashi T.,Acute safety study of simian immunodeficiency virus from African green monkey (SIVagm)-based lentiviral vector for retinal gene transfer in nonhuman primates.,Human Gene Therapy,20:943-954,2009.09.
14. Ikeda Y, Yonemitsu Y, Miyazaki M, Kohno RI, Murakami Y, Murata T, Tabata T, Ueda Y, Ono F, Suzuki T, Ageyama N, Terao K, Hasegawa M, Sueishi K, Ishibashi T.,Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors.,Human Gene Therapy,20:573-579,2009.06.
15. Taniguchi K, Sasaki K, Watari K, Yasukawa H, Imaizumi T, Ayada T, Okamoto F, Ishizaki T, Kato R, Kohno R, Kimura H, Sato Y, Ono M, Yonemitsu Y, Yoshimura A.,Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis.,PLoS ONE.,4:e5467,2009.05.
16. Kinoh H, Inoue M, Komaru A, Ueda Y, Hasegawa M, Yonemitsu Y.,Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies.,Gene Therapy,16:392–403,2009.11.
17. Tatsuta K, Tanaka S, Tajiri T, Shibata S, Inoue M, Hasegawa M, Ueda Y, Suita S, Sueishi K, Taguchi T, Yonemitsu Y.,Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene.,Gene Therapy ,16: 240–251,2011.07.
18. Inoue H, Iga M, Xin M, Asai S, Nabeta H, Kurita R, Nakayama M, Suehiro Y, Okano S, Inoue M, Katagiri T, Takayama K, Yonemitsu Y, Hasegawa M, Nakamura Y, Nakanishi Y, Tani K.,Non-transmissible SeV encoding GM-CSF is a novel and potent vector system to produce autologous tumor vaccines.,Cancer Science,99:2315-2326,2008.10.
19. Murakami Y, Ikeda Y, Yonemitsu Y, Onimaru M, Nakagawa K, Kohno R-I, Miyazaki M, Nakamura M, Yabe T, Hasegawa M, Ishibashi T, Sueishi K.,Inhibition of nuclear translocation of apoptosis-inducing factor is an essential mechanism for pigment epithelium-derived factor-mediated neuroprotection in retinal degeneration,The American Journal of Pathology,173:1326-1338,2011.07.
20. Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Kohno RI, Murakami Y, Sakamoto T, Inoue M, Ueda Y, Hasegawa M, Tobimatsu S, Ishibashi T.,Synergistic neuroprotective effect via simian lentivirus-mediated simultaneous gene transfer of PEDF and FGF-2 in rodent models of retinitis pigmentosa.,The Journal of Gene Medicine,10:1273-1281,2008.12.
21. Fujii T, Onimaru M, Yonemitsu Y, Kuwano H, Sueishi K.,Statins restore blood flow of ischemic limb in diabetic microangiopathy via upregulation of eNOS/NO, but not via PDGF-BB expression.,Am J Physiol, Heart Circ Physiol ,294:H2785-H2791,2008.04.
22. Fujii T, Yonemitsu Y, Onimaru M, Inoue M, Hasegawa M, Kuwano H, Sueishi K.,VEGF Function for Upregulation of Endogenous PlGF Expression during FGF-2-mediated Therapeutic Angiogenesis.,Atherosclerosis ,200:51-57,2008.02.
23. Murakami Y, Ikeda Y, Yonemitsu Y, Tanaka S, Kondo H, Okano S, Kohno RI, Miyazaki M, Inoue M, Hasegawa M, Ishibashi T, Sueishi K.,Newly developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.,The Journal of Gene Medicine ,10:165-176,2008.02.
24. Yoshida K, Yonemitsu Y, Tanaka S, Yoshida S, Shibata S, Kondo H, Okano S, Ishikawa F,
Akashi K, Inoue M, Hasegawa M, Sueishi K.,In vivo repopulation of cytoplasmically gene-transferred hematopoietic cells by temperature sensitive mutant of recombinant Sendai viral vector. ,Biochemical and Biophysical Research Communications,361:811-816,2007.07.
25. Taniguchi K, Kohno R, Ayada T, Kato R, Morisada T, Oike Y, Yonemitsu Y, Maehara Y, Yoshimura A.,Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor-3 signaling.,Molecular and Cellular Biology,27: 4541-4550,2007.04.
26. Takeuchi K, Itoh H, Yonemitsu Y, Matsumoto T, Kume M, Komori K, Maehara Y.,In vivo reduction of nuclear factor-κB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia of injured rabbit carotid arteries.,Surgery Today,37:575-583,2007.07.
27. Tanaka S, Yonemitsu Y, Yoshida K, Okano S, Kondo H, Inoue M, Hasegawa M, Matsumoto K, Suita S, Taguchi T, Sueishi K. ,Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice,Gene Therapy,14:1017-1028,2007.01.
28. Taniguchi K, Ayada T, Ichiyama K, Kohno R, Yonemitsu Y, Minami Y, Kikuchi A, Maehara Y, Yoshimura A.,Sprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling.,Biochemical and Biophysical Research Communications,352:896-902,2007.01.
29. Fujii T, Yonemitsu Y, Tanii M, Nakano T, Egashira K, Takehara T, Inoue M, Hasegawa M, Kuwano H, Sueishi K.,Non-endothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization - critical role of the inflammatory/arteriogenic pathway,Arterioscler Thromb Vasc Biol ,26: 2483-2489,2006.11.
30. Ikeda Y, Yonemitsu Y, Onimaru M, Nakano T, Miyazaki M, Kohno R, Nakagawa K, Ueno A, Sueishi K, Ishibashi T.,The regulation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium.,Experimental Eye Research,83:1031-1040,2006.11.
31. Kohno RI, Ikeda Y, Yonemitsu Y, Hisatomi T, Yamaguchi M, Miyazaki M, Ishibashi T, Sueishi K.,Sphere formation of ocular epithelial cells in ciliary body is a reprogramming system for neural differentiation,Brain Research,2006.06.
32. Nagata S, Okano S, Yonemitsu Y, Nakagawa K, Shoji F, Hashimoto R, Tomita Y, Yoshikai Y, Shimada M, Maehara Y, Sueishi K.,Critical Roles of memory T-cells and anti-donor immunoglobulin in rejection of allogenic bone marrow cells in sensitized recipient mice.,Transplantation,2006.09.
33. Yoshizumi T, Yonemitsu Y, Ikeda Y, Kaneda Y, Yanaga K, Sugimachi K, Sueishi K.,Tumor necrosis factor-α antisense transfer remarkably improves hepatic graft viability.,Liver International,26:451-456,2006.05.
34. Kaneko K, Yonemitsu Y, Fujii T, Onimaru M, Inoue M, Hasegawa M, Onohara T, Maehara Y, Sueishi K.,A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephrophathic metabolic syndrome in severe hind limb ischemia.,Am J Physiol, Heart Circ Physiol,290:H1484-92,2006.04.
35. Yamaoka T, Yonemitsu Y, Komori K, Baba H, MatsumotoT, Onohara T, Maehara Y.,Ex vivo electroporation as a potent new strategy for non-viral gene transfer into autologous vein grafts,Am J Physiol, Heart Circ Physiol , 289:H1865-H1872,2006.11.
36. Baba H, Yonemitsu Y, Nakano T, Miyazaki M, Ikeda Y, Sumiyoshi S, Ueda Y, Hasegawa M, Yoshino I, Maehara Y, Sueishi K.,Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, PEDF, in human atherosclerotic plaques.,Arterioscler Thromb Vasc Biol,25:1938-1944,2005.06.
37. Tomoda T, Aishima M, Takano N, Nakano T, Seki N, Yonemitsu Y, Sueishi K, Naito S, Ito Y, Teramoto N.,The effects of flavoxate hydrochloride on voltage-dependent L-type Ca2+ currents in human urinary bladder.,The British Journal of Pharmacology,2005.09.
38. Shikada Y, Yonemitsu Y, Koga T, Onimaru M, Okano S, Saata S, Nakagawa K, Yoshino I, Maehara Y, Sueishi K.,PDGF-AA is an essential and autocrine regulator of VEGF expression in non-small cell lung carcinomas.,Cancer Research , 65:7241-7248,2005.08.
39. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, Akishima Y, Ishii T, Iida M, Sueishi K.,Angiogenesis/lymphangiogenesis and expression of lymphangiogenic factors in atherosclerotic intima of human coronary arteries.,Human Pathology,2005.04.
40. Celec P, Gardlik R, Palffy R, Hodosy J, Stuchlik S, Drahovska H, Jurkovicova I, Hulin I, Jakubovsky J, Kudela M, Yonemitsu Y. ,Vascular enbdothelial growth factor induced angiogenesis after transformation of E. Coli– An alternative gene therapy.,Medical Hypotheses,64:505-511,2005.07.
41. Ohtani K, Egashira K, Hiasa KI, Zhao Q, Kitamoto S, Ishibashi M, Usui M, Inoue S, Yonemitsu Y, Sueishi K, Sata M, Shibuya M, Sunagawa K.,Blockade of Vascular Endothelial Growth Factor Suppresses Experimental Restenosis After Intraluminal Injury by Inhibiting Recruitment of Monocyte Lineage Cells.,Circulation,2004.10.
42. Matsuo Y, Hashimoto S, Koga T, Yonemitsu Y, Yoshino I, Sugimachi K, Masuda K, Sueishi K.,Growth pattern correlates with the distribution of basement membrane and prognosis in lung adenocarcinoma. ,Pathology Research and Practice,2004.07.
43. Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, Hasehawa M, Yonemitsu Y, Komiya S, Yoshimura A.,The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.,Oncogene,2004.07.
44. Miyoshi K, Wakioka T, Nishinakamura H, Kamio M, Yang L, Inoue M, Hasehawa M, Yonemitsu Y, Komiya S, Yoshimura A.,The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization.,Oncogene,2004.07.
45. Tsutsumi N, Yonemitsu Y, Shikada Y, Onimaru M, Tanii M, Okano S, Hasegawa M, Maehara Y, Hashizume M, Sueishi K.,Essential role of PDGFRα/p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRα/p70S6K during angiogenesis.,Circulation Research,94:1186-1194,2004.05.
46. Suzuki H, Kobayashi H, Sato F, Yonemitsu Y, Nakashima Y, Sueishi K.,Plaque-stabilizing effect of Pitabastatin in Watanabe heritable hyperlipidemic rabbits.,Journal of Atherosclerosis and Thrombosis,10:109-116,2003.10.
47. Ikeda Y, Goto Y (equal contribution), Yonemitsu Y, Miyazaki M, Sakamoto T, Ishibashi T, Ueda Y, Hasegawa M, Tobimatsu S, Sueishi K.,Simian Immunodeficiency Virus-Based Lentiviral Vector For Retinal Gene Transfer: a preclinical safety,Gene Therapy,10:1161-1169,2003.09.
48. Okano S, Yonemitsu Y, Nagata S, Sata S, Nakagawa K, Tomita Y, Nakashima Y, Hasegawa M, Sueishi K.,Recombinant Sendai virus vectors for activated T-lymphocytes,Gene Therapy,10:1381-1391,2003.08.
49. Miyazaki M, Ikeda Y, Yonemitsu Y, Goto Y, Sakamoto T, Tabata T, Ueda Y, Hasegawa M, Tobimatsu S, Ishibashi T, Sueishi K.,Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects,Gene Therapy,10:1503-1511,2003.08.
50. Jiang C, Koyabu N, Yonemitsu Y, Shimazoe T, Watanabe S, Naito M, Tsuruo T, Ohtani H, Sawada Y.,In vivo delivery of glial cell-derived neurotrophic factor across blood-brain barrier by gene transfer into,Human Gene Therapy,14:1181-1192,2003.08.
51. Shoji T, Yonemitsu Y, Komori K, Tanii M, Itoh H, Sata S, Shimokawa H, Hasegawa M, Sueishi K, Maehara Y.,Intramuscular gene transfer of FGF-2 attenuates regenerative endothelial dysfunction and inhibits,American Journal of Physiology,285:H173-H182,2003.07.
52. Shoji F, Yonemitsu Y, Okano S, Yoshino I, Nakagawa K, Nakashima Y, Hasegawa M, Sugimachi K, Sueishi K.,Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplantation bronchiolitis obliterans in mice.,Gene Therapy,10:213-218,2003.02.
53. Onimaru M, Yonemitsu Y, Nakagawa K, Masaki I, Tanii M, Okano S, Shirasuna K, Hasegawa M, Sueishi K.,FGF-2 gene transfer can stimulate HGF expression, irrespective of hypoxia-mediated downregulation in ischemic limbs.,Circulation Research,91:723-730,2002.11.
54. Ikeda Y, Yonemitsu Y, Ishibashi T, Murata T, Ueno H, Kato A, Nagai Y, Fukumura M, Inomata H, Hasegawa M, Sueishi K.,Recombinant Sendai virus-mediated gene transfer to the retinal tissue of adult rats: efficient gene transfer by brief exposure.,Experimental Eye Research,75:39-48,2002.07.
55. Ohta S, Komori K, Yonemitsu Y, Onohara T, Matsumoto T, Sugimachi K.,Intraluminal gene transfer of endothelial nitric oxide synthase partially supresses neointimal formation of vein grafts of hypercholesterolemic rabbits: a limited biological effect as a result of the loss of medial smooth muscle cells.,Surgery,131:644-653,2002.06.
56. Koga T, Hashimoto S, Yonemitsu Y, Sugio K, Matsuo Y, Mojtahedzadeh S, Yoshino I, Fujii H, Sugimachi K, Sueishi K.,Lung adenocarcinoma with bronchio-alveolar carcinoma component frequently associates foci of high grade atypical adenomatous hyperplasia.,American Journal of Clinical Pathology,117: 464-470,2002.03.
57. Kume M, Komori K, Matsumoto T, Onohara T, Takeuchi K, Yonemitsu Y, Sugimachi K. ,Administration of a decoy against the AP-1 binding site suppresses neointimal thickening in rabbit balloon injured arteries.,Circulation,105:1226-1232,2002.03.
58. Matsumoto T, Komori K, Shouji T, Kuma S, KumeM, Yamaoka T, Mori E, Furuyama T, Yonemitsu Y, Sugimachi K.,Successful and optimized in vivo gene transfer to rabbit carotid artery mediated by electronic pulse.,Gene Therapy,8:1174-1179,2001.08.
59. Koga T, Hashimoto S, Sugio K, Yoshino I, Nakagawa K, Yonemitsu Y, Sugimachi K, Sueishi K.,Heterogenous distribution of p53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression, rather than with p53 gene mutation.,International Journal of Cancer,95:232-239,2001.07.
60. Koga T, Hashimoto S, Sugio K, Yoshino I, Mojtahedzadeh S, Matsuo Y, Yonemitsu Y, Sugimachi K, Sueishi K.,Clinico-pathological and molecular evidence indicating the independency of bronchio-alveolar components from other subtypes of human lung adenocarcinoma.,Clinical Cancer Research,7:1730-1738,2001.06.
61. Masaki I, Yonemitsu Y, Komori K, Ueno H, Nakashima Y, Nakagawa K, Fukumura M, Kato A, Hasan MK, Nagai Y, Sugimachi K, Hasegawa M, Sueishi K.,Recombinant Sendai Virus-mediated Gene Transfer to Vasculature: a new class of efficient gene transfer vector to the vascular system.,The FASEB Journal,15:1294-1296,2001.05.
62. Teramoto N, Yunoki T, Takano M, Yonemitsu Y, Masaki I, Sueishi K, Brading AF Ito Y.,Dual action of ZD6169, a novel K+ channel opener, on ATP-sensitive K+ channels in pig urethral myocytes.,British Journal of Pharmacology,133:154-164,2001.05.
63. Hasegawa H, Shimada M, Yonemitsu Y, Utsunomiya T, Gion T, Kaneda Y, Sugimachi K.,Preclinical and therapeutic utility of HVJ-liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex thymidine kinase.,Cancer Gene Therapy,8:252-258,2001.04.
64. Komori K, Shoji T, Furuyama T, Yonemitsu Y, Mori E, Yamaoka T, Matsumoto T, Sugimachi K.,Non-penetrating vascular clips anastomosis inhibited intimal thickening under poor runoff conditions in canine autogenous vein grafts,European Journal of Vascular and Endovascular Surgery,21: 241-247,2001.03.
65. Ishida M, Komori K, Yonemitsu Y, Matsumoto T, Onohara T, Sugimachi K.,Immunohistochemical phenotypic alterations of rabbitt autologous vein grafts implanted under arterial circulation with or without poor distal runoff -implications of vein graft remodeling.
,Atherosclerosis ,154:345-354,2001.02.
66. Teramoto N, Yunoki T, Tanaka K, Takano M, Masaki I, Yonemitsu Y, Sueishi K, Ito, Y.
,The effects of caffeine on ATP-sensitive K+ currents in smooth muscle cells from pig urethra.
,British Journal of Pharmacology,131: 515-523,2000.10.
67. Yonemitsu Y, Kitson C, Ferrari S, Farley R, Griesenbach U, Dian J, Steel R, Phillipe S, Zhu J, Jeffery PK, Kato A, Hasan MK, Masaki I, Nagai Y, Fukumura M, Hasegawa M, Geddes DM, Alton EWFW.,Efficient gene transfer to the airway epithelium using recombinant Sendai virus.,Nature Biotechnology,18: 970-973,2000.09.
68. Duan H, Imafuku S, Yonemitsu Y, Yasumoto S, Koga T, Nagae S, Kiryu H, Imayama S, Sueishi K, Hori Y, Furue M.,The proliferative properties of tumor cells differentially correlate with the host immune responses in anogenital Bowen's disease.,Journal of Dermatological Science,20:53-62,1999.05.
69. Namoto M, Yonemitsu Y, Nakagawa K, Hashimoto S, Kaneda Y, Nawata H, Sueishi K.
,Heterogenous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection.
,International Journal of Oncology ,12: 777-784,1998.04.
70. Yonemitsu Y, Tanaka S, Kaneda Y, Nakashima Y, Komori K, Sugimachi K, Sueishi K. ,Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. ,Circulation Research,82: 147-156,1998.02.
71. Komori K, Yamamura S, Ishida M, Matsumoto T, Kuma S, Eguchi D, Yonemitsu Y, OnoharaT, Sugimachi K.,Acceleration of impairment of endothelium-dependent responses under poor runnoff conditions in canine autogenous vein grafts.,Europian Journal of Vascular and Endovascular Surgery,14: 475-481,1997.12.
72. Fukumoto Y, Shimokawa H, Kozai T, Kadokami T, Kuwata K, Yonemitsu Y, Kuga T, Egashira K, Sueishi K, Takeshita A. ,Vasculoprotective role of inducible nitric oxide synthase at coronary inflammatory lesions induced by chronic treatment with interleukin-1β in pigs in vivo. ,Circulation,96: 3104-3111,1997.11.
73. Komori K, Matsumoto T, Ishida M, Kuma S, Yonemitsu Y, Eguchi D, Sugimachi K.,Enhancement of nitric oxide production after arterial reconstruction in patients with arteriosclerosis obliterans.,Journal of Vascular Surgery, 26: 657-662,1997.10.
74. Wei C, Komori K, Mawatari K, Yonemitsu Y, Sugimachi K.,Preserved endothelial function and morphology in canine arterial grafts under conditions of poor distal runoff.,Journal of Surgical Research ,71: 117-122,1997.08.
75. Yonemitsu Y, Kaneda Y, Muraishi A, Yoshizumi T, Sugimachi K, Sueishi K. ,HVJ (Sendai virus) cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium.,Gene Therapy,4: 631-638,1997.07.
76. Yonemitsu Y, Kaneda Y, Komori K, Hirai K, Sugimachi K, Sueishi K.,The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo.,Biochemical and Biophysical Research Communications,231: 447-451,1997.02.
77. Fukumoto Y, Shimokawa H, Ito A, Kadokami T, Yonemitsu Y, Aikawa M, Owada K, Egashira K, Sueishi K, Nagai R, Yazaki Y, Takeshita A.,Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs.,Journal of Cardiovascular Pharmacology, 29: 222-231,1997.02.
78. Yonemitsu Y, Kaneda Y, Morishita R, Nakagawa K, Nakashima Y, Sueishi K. ,Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (HVJ)-liposomes: an effective tool for the in vivo study of arterial diseases.,Laboratory Investigation,75: 313-323,1996.09.
79. Yonemitsu Y, Nakagawa K, Tanaka S, Mori R, Sugimachi K, Sueishi K.,In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. ,Laboratory Investigation,74; 723-736,1996.04.